Volcanics Venture logo

Volcanics Venture

Asia, Shanghai, China, Changning

Description

Volcanics Venture, established in 2016 by veteran investor Zhang Jun, is a prominent venture capital firm based in Shanghai, China. The firm primarily focuses on capital investments in early and growth-stage companies, with a strategic emphasis on two core sectors: internet innovation (encompassing TMT) and healthcare. Their investment philosophy is rooted in identifying disruptive technologies and business models that have the potential for significant market impact within the Chinese landscape. Volcanics Venture aims to partner with ambitious entrepreneurs, providing not just capital but also strategic guidance and operational support to foster sustainable growth.

The firm has successfully raised substantial capital across multiple funds, demonstrating strong investor confidence. For instance, their third USD fund successfully closed at $300 million in 2021, underscoring their capacity to deploy significant capital into promising ventures. Volcanics Venture typically targets companies in their Series A to Series C funding rounds, indicating a preference for businesses that have moved beyond the seed stage but still possess considerable growth runway. Their approach involves deep industry research and a hands-on engagement model, aiming to add value beyond mere financial injection.

Volcanics Venture's typical first cheque sizes range from approximately $5 million to $25 million, reflecting their commitment to providing meaningful capital injections for their target stages. This range allows them to support a diverse portfolio of companies, from those just beginning to scale to more established growth-stage enterprises. The firm's track record includes early investments in several now-prominent technology companies, showcasing their acumen in identifying future market leaders. Their long-term vision and commitment to fostering innovation position them as a key player in China's dynamic venture capital ecosystem.

Investor Profile

Volcanics Venture has backed more than 22 startups, with 2 new investments in the last 12 months alone. The firm has led 3 rounds, about 14% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Angel rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biotechnology, Health Care, Artificial Intelligence (AI).
  • Typical check size: $5M – $25M.

Stage Focus

  • Series A (50%)
  • Series B (27%)
  • Angel (9%)
  • Seed (9%)
  • Series C (5%)

Country Focus

  • China (73%)
  • United States (27%)

Industry Focus

  • Biotechnology
  • Health Care
  • Artificial Intelligence (Ai)
  • Biopharma
  • Precision Medicine
  • Software
  • Robotics
  • Medical Device
  • Manufacturing
  • Automotive
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Volcanics Venture frequently co-invest with?

Nan Fung Life Sciences
North America, California, United States, San Francisco
Co-Investments: 2
Seven Seas Partners
North America, California, United States, Menlo Park
Co-Investments: 2
Baidu Ventures
Asia, Beijing, China, Beijing
Co-Investments: 3
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 2
Nest.Bio Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 3
PB
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 2
BioVenture
Asia, Jiangsu, China, Suzhou
Co-Investments: 2
Emerging Technology Partners
North America, California, United States, San Francisco
Co-Investments: 2

Which angels does Volcanics Venture often collaborate with?

SP
North America, Washington, United States, Seattle
Shared Deals: 1
TZ
North America, United States
Shared Deals: 1

What are some of recent deals done by Volcanics Venture?

EVAS Intelligence

Nansha, Guangdong, China

EVAS Intelligence is an autonomous driving chip startup.

Autonomous VehiclesSemiconductor
Series AJan 20, 2025
Unisic

Suzhou, Jiangsu, China

Unisic designs and manufactures silicon carbide core power components.

ElectronicsEnergyIndustrialManufacturing
Series BDec 3, 2024
Amount Raised: $27,454,426
FlowUs

Beijing, Beijing, China

FlowUs is a new generation of knowledge management and collaboration platform that offers productivity tools for individuals and teams.

AppsCollaborationDocument ManagementKnowledge Management
AngelMar 22, 2022
Amount Raised: $1,570,746
BOOLV

Shenzhen, Guangdong, China

Boolean vector BOOLV is an AI video generation SaaS service provider.

Artificial Intelligence (AI)
Series AMar 1, 2022
Amount Raised: $10,000,000
Alluxio

San Mateo, California, United States

Data Orchestration for AI and Analytics in the Cloud

AnalyticsArtificial Intelligence (AI)Open SourceSoftware
Series CNov 16, 2021
Amount Raised: $50,000,000
Thinktech

Shanghai, Shanghai, China

Thinktech is a design and manufacturing company that specializes in producing automotive-grade semiconductors.

AutomotiveManufacturingSemiconductor
Series AOct 28, 2021
Amount Raised: $15,644,800
Cloudpick Technology

Shanghai, Shanghai, China

Cloudpick Technology is a high-tech enterprise specializing in the development of computer vision and AI technologies

Artificial Intelligence (AI)Computer VisionRobotics
Series AJul 20, 2020
Polaris Biology

Shanghai, Shanghai, China

Polaris Biology is a medical technology company specializing in the development and clinical application.

BiopharmaBiotechnologyHealth CareMedical
Series BJun 24, 2020
Amount Raised: $9,889,520
Alluxio

San Mateo, California, United States

Data Orchestration for AI and Analytics in the Cloud

AnalyticsArtificial Intelligence (AI)Open SourceSoftware
Series BApr 16, 2020
Amount Raised: $7,000,000
RootPath Genomics

Cambridge, Massachusetts, United States

RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.

BiotechnologyPrecision Medicine
Series AJan 5, 2020
Amount Raised: $11,000,000